Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease.
Hirotaka ShimizuRyo EbanaTakahiro KudoTakuro SatoTomoko HaraKenji HosoiMasaaki UsamiMasashi YoshidaIchiro TakeuchiHiroshi NakaseItaru IwamaKatsuhiro AraiToshiaki ShimizuPublished in: Journal of gastroenterology (2022)
Both FCP and FIT correlate well with endoscopic activity in pediatric patients with IBD. The FCP is a superior marker for predicting MH.